CERUS CP (CERS)

Overview Price 3.22 Price Change Today +$0.03 (+0.94%) P&P rating Zacks Rank 3 - HOLD Open Price $3.21 Previous Close $3.19 Daily Range $3.15 - $3.24 52-Week Range $1.92 - $3.67 Volume 553,790 Cerus Corporation is developing medical products based on a platform technology that prevents nucleic acid replication. The company's initial application of this technology is the development of systems to inactivate viruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. Other Resources for CERS Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Company News for March 07, 2011 March 7, 2011 Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.   Brokerage Analyst Recommendations 3 Brokerage Firms Covering CERS   Strong Buy 2 Buy 0 Hold 1 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 1.67   CERS Ratings: BUY  SELL  HOLD CERS Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 12 Buy 0 Sell   Top Buy Analysis BUY: CERS Company: CERUS CORPORATION Points: -10.47 Start Price: $2.97 Start Date: 05/17/2010 10:19 PM mdmoney P&P Score: 98.37 Recs: The INTERCEPT system is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. The Company markets the INTERCEPT system for both platelets and plasma in Europe and the Middle East. Imagine if the FDA approves it in the USA. Comments: 0 | Comment More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

No related Blog Posts.

Commentary

BUY: CERUS CORPORATION (CERS) Start Price: $2.97 Points: -10.47 Created: 05/17/2010 The INTERCEPT system is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. The Company markets the INTERCEPT system for both platelets and plasma in Europe and the Middle East. Imagine if the FDA approves it in the USA. Comments: 0 | Comment mdmoney Recs:

BUY: CERUS CORPORATION (CERS) Start Price: $10.23 Points: -60.60 Created: 01/01/2008 Comments: 0 | Comment DrPhysics Recs:

BUY: CERUS CORPORATION (CERS) Start Price: $10.27 Points: -60.72 Created: 01/01/2008 Comments: 0 | Comment DonaldJ Recs:

BUY: CERUS CORPORATION (CERS) Start Price: $8.70 Points: -55.07 Created: 01/01/2008 Comments: 0 | Comment chub123 Recs:

BUY: CERUS CORPORATION (CERS) Start Price: $5.59 Points: -34.48 Created: 01/01/2008 Comments: 0 | Comment daxx Recs:

BUY: CERUS CORPORATION (CERS) Start Price: $7.85 Points: -51.06 Created: 01/01/2008 Comments: 0 | Comment MitchellMoney Recs:

BUY: CERUS CORPORATION (CERS) Start Price: $14.14 Points: -69.31 Created: 01/01/2008 Comments: 0 | Comment sbntradingzweig Recs:

BUY: CERUS CORPORATION (CERS) Start Price: $8.10 Points: -52.33 Created: 01/01/2008 Comments: 0 | Comment wpa Recs:

BUY: CERUS CORPORATION (CERS) Start Price: $6.41 Points: -41.84 Created: 01/01/2008 Comments: 0 | Comment GCris Recs:

BUY: CERUS CORPORATION (CERS) Start Price: $6.95 Points: -45.75 Created: 01/01/2008 Comments: 0 | Comment eloy Recs:

Pages: [ 1 ]  2  >>

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
mdmoney	98.37	BUY	Six Months to a Year	05/17/2010	$2.97	$3.22 (+0.31%)	+8.42%	+18.89%	-10.47	view close
DrPhysics	53.62	BUY	Six Months to a Year	01/01/2008	$10.23	$3.22 (+0.31%)	-68.52%	-7.92%	-60.60
DonaldJ	9.46	BUY	Six Months to a Year	01/01/2008	$10.27	$3.22 (+0.31%)	-68.65%	-7.92%	-60.72
chub123	58.27	BUY	Six Months to a Year	01/01/2008	$8.70	$3.22 (+0.31%)	-62.99%	-7.92%	-55.07
daxx	13.16	BUY	Six Months to a Year	01/01/2008	$5.59	$3.22 (+0.31%)	-42.40%	-7.92%	-34.48
MitchellMoney	40.97	BUY	Six Months to a Year	01/01/2008	$7.85	$3.22 (+0.31%)	-58.98%	-7.92%	-51.06
sbntradingzweig	40.97	BUY	Six Months to a Year	01/01/2008	$14.14	$3.22 (+0.31%)	-77.23%	-7.92%	-69.31
wpa	28.55	BUY	Six Months to a Year	01/01/2008	$8.10	$3.22 (+0.31%)	-60.25%	-7.92%	-52.33
GCris		BUY	Six Months to a Year	01/01/2008	$6.41	$3.22 (+0.31%)	-49.77%	-7.92%	-41.84
eloy	40.97	BUY	Six Months to a Year	01/01/2008	$6.95	$3.22 (+0.31%)	-53.67%	-7.92%	-45.75

Pages: [ 1 ]  2  >>